These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37955319)

  • 1. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
    Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
    Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
    Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
    Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
    Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
    Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
    Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
    Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
    Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evaluation of pheochromocytoma and paraganglioma.
    Eisenhofer G; Peitzsch M
    Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
    Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
    Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
    Bokuda K; Yatabe M; Seki Y; Ichihara A
    Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
    Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
    Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
    Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
    Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
    Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
    Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Assessment of Pheochromocytoma and Paraganglioma.
    Eisenhofer G; Pamporaki C; Lenders JWM
    Endocr Rev; 2023 Sep; 44(5):862-909. PubMed ID: 36996131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
    Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
    Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.